Indegene (INDGN) | Stock Overview & Key Data
Indegene Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹736.30 on September 30, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Indegene
INDGN
|
118.46B Mid-cap | 0.20% | -2.51% | 10.25% | -2.05% | -0.02% | -13.15% | -6.04% | -6.04% | -6.04% | -6.04% | -6.04% |
| 240.58B Large-cap | 4.18% | 1.63% | 28.17% | 2.31% | 1.41% | 11.29% | -11.15% | -11.15% | -11.15% | -11.15% | -11.15% | |
|
Sagility India
SAGILITY
|
193.67B Mid-cap | -2.97% | -3.53% | -2.88% | -19.64% | -22.86% | 3.82% | 43.95% | 43.95% | 43.95% | 43.95% | 43.95% |
|
JSW Steel
JSTL
|
1.59B Small-cap | -8.57% | -6.10% | 14.25% | 23.41% | 21.31% | 101.16% | 82.55% | -11.14% | 220.23% | 218.39% | 218.39% |
|
Sun Pharmaceutical
SUNPHARMA
|
3.88T Large-cap | -3.03% | -1.92% | 2.17% | -1.01% | 3.92% | 7.25% | 79.99% | 166.96% | 144.01% | 669.48% | 2,278.32% |
Ownership & Short Interest
Calculate Your Indegene Investment Returns
Long-Term Investment Performance Analysis
Indegene stock price in May 2024 was ₹555.10, A ₹1,000.00 lump sum investment in Indegene made 2 years ago would be worth approximately ₹936.68 today, representing a negative return of -6.33%. This translates to an annualized return (CAGR) of -3.13%.
2 Years Investment Scenario (May 2024 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is INDGN's 52-week high and low?
- In the last 52 weeks, Indegene reached a high of ₹632.90 (on June 3, 2025) and a low of ₹414.00 (on March 23, 2026).
- What is the market cap and P/E ratio for INDGN?
- Curious about Indegene's size and valuation? Its market capitalization stands at 118.46B. When it comes to valuation, the P/E ratio (trailing twelve months) is 27.09, and the forward P/E (looking ahead) is 22.75.
- Does INDGN pay dividends? If so, what's the yield?
- Yes, Indegene is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.34%, and the company has paid an average of ₹0.67 per share annually over the past 3 years.
- Who are Indegene's main competitors or similar companies to consider before investing?
When looking at Indegene, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Inventurus Knowledge
IKS240.58B Healthcare Health Information Services 11.29% -11.15% Sagility India
SAGILITY193.67B Healthcare Health Information Services 3.82% 43.95% JSW Steel
JSTL1.59B Healthcare Health Information Services 101.16% 82.55% Sun Pharmaceutical
SUNPHARMA3.88T Healthcare Drug Manufacturers - Specialty & Generic 7.25% 79.99% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Indegene Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Indegene's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 15.55%, the Debt to Equity ratio from the most recent quarter is 4.26, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for INDGN?
- Looking at Indegene's growth, its revenue over the trailing twelve months (TTM) was INR33B. Compared to the same quarter last year (YoY), quarterly revenue grew by 30.80%, and quarterly earnings saw a YoY growth of -6.20%.
- How much of INDGN stock is held by insiders and institutions?
- Wondering who owns Indegene stock? Company insiders (like executives and directors) hold about 57.07% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 25.16%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.